Kevin Eastwood

Kevin Eastwood is the Executive Vice President of Corporate Development at Plexium. Kevin has over 20 years of experience in the biotech industry and has held various leadership positions in corporate development and business development. Prior to joining Plexium, Kevin was the Vice President of Corporate Development at the California Institute for Biomedical Research (Calibr). Kevin also served as the Senior Director of Strategic Partnerships at The Scripps Research Institute and the Senior Director of Corporate Development at Gilead Sciences. Kevin is a founding member of eFFECTOR Therapeutics and served as its Senior Vice President of Corporate Development. Kevin also served as the Senior Vice President of Corporate Development at Anadys Pharmaceuticals and as the Vice President of Corporate Development at Ambrx. Kevin founded Achillion Pharmaceuticals in 1998 and served as its Senior Vice President of Business Development for six years. Kevin began their career in the biotech industry as a Manager of Business Development at Agouron Pharmaceuticals and later worked as an Institutional Sales Specialist at Hoechst Marion Roussel, Marion Merrell Dow, and Marion Labs.

Kevin Eastwood obtained a B.S. from Missouri State University in 1986. Kevin's fields of study were biology and chemistry.

The team of Kevin Eastwood is responsible for the corporate development of the company. This includes the financial and operational aspects of the company as well as the research and development of new drugs.